{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:06:14Z","timestamp":1787933174700,"version":"build-2784847793"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The twitcher mouse is an animal model of Krabbe's disease (KD), which is a neurodegenerative lysosomal storage disorder resulting from the absence of functional lysosomal enzyme galactocerebrosidase (GALC). This disease affects the central and peripheral nervous systems and in its most severe form results in death before the age of 2 in humans and approximately 30\u201340 days in mice. This study evaluates the effect of intracerebroventricular administration of mesenchymal stem cells derived from adipose tissue (ASCs) and bone marrow (BMSCs) on the pathology of KD. Subsequent to the intracerebroventricular injection of ASCs or BMSCs on postnatal day (PND) 3\u20134, body weight, lifespan, and neuromotor function were evaluated longitudinally beginning on PND15. At sacrifice, tissues were harvested for analysis of GALC activity, presence of myelin, infiltration of macrophages, microglial activation, inflammatory markers, and cellular persistence. Survival analysis curves indicate a statistically significant increase in lifespan in stem cell-treated twitcher mice as compared with control twitcher mice. Body weight and motor function were also improved compared with controls. The stem cells may mediate some of these benefits through an anti-inflammatory mechanism because the expression of numerous proinflammatory markers was downregulated at both transcriptional and translational levels. A marked decrease in the levels of macrophage infiltration and microglial activation was also noted. These data indicate that mesenchymal lineage stem cells are potent inhibitors of inflammation associated with KD progression and offer potential benefits as a component of a combination approach for in vivo treatment by reducing the levels of inflammation.<\/jats:p>","DOI":"10.1002\/stem.555","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T15:14:24Z","timestamp":1289315664000},"page":"67-77","source":"Crossref","is-referenced-by-count":60,"title":["Mesenchymal Lineage Stem Cells Have Pronounced Anti-Inflammatory Effects in the Twitcher Mouse Model of Krabbe's Disease"],"prefix":"10.1093","volume":"29","author":[{"given":"Cynthia B.","family":"Ripoll","sequence":"first","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Department of Pharmacology, Tulane University School of Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Flaat","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Department of Biochemistry, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Klopf-Eiermann","sequence":"additional","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Fisher-Perkins","sequence":"additional","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia B.","family":"Trygg","sequence":"additional","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittni A.","family":"Scruggs","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Tulane University School of Medicine, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie L.","family":"McCants","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Paige","family":"Leonard","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy F.","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Tulane University School of Medicine, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Eagle","sequence":"additional","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Division of Comparative Pathology, Tulane National Primate Research Center, Baton Rouge, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Teh","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Gimble","sequence":"additional","affiliation":[{"name":"Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Bunnell","sequence":"additional","affiliation":[{"name":"Division of Regenerative Medicine, Tulane National Primate Research Center, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Department of Pharmacology, Tulane University School of Medicine, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA"},{"name":"Department of Biochemistry, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"2022011210343332600_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe's disease): Deficiency of galactocerebroside beta-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011210343332600_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum Mutat"},{"key":"2022011210343332600_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-2275(20)39839-4","article-title":"Krabbe disease: A galactosylsphingosine (psychosine) lipidosis","volume":"21","author":"Svennerholm","year":"1980","journal-title":"J Lipid Res"},{"key":"2022011210343332600_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.6719111","article-title":"Progressive accumulation of toxic metabolite in a genetic leukodystrophy","volume":"224","author":"Igisu","year":"1984","journal-title":"Science"},{"key":"2022011210343332600_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00005072-199906000-00009","article-title":"An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy","volume":"58","author":"Taniike","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022011210343332600_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jgm.924","article-title":"Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain","volume":"8","author":"Dolcetta","year":"2006","journal-title":"J Gene Med"},{"key":"2022011210343332600_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mgme.2000.2990","article-title":"Krabbe disease: Genetic aspects and progress toward therapy","volume":"70","author":"Wenger","year":"2000","journal-title":"Mol Genet Metab"},{"key":"2022011210343332600_bib8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"2022011210343332600_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet Med"},{"key":"2022011210343332600_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The Twitcher mouse: An enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res"},{"key":"2022011210343332600_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-3639.1995.tb00601.x","article-title":"The twitcher mouse: A model for Krabbe disease and for experimental therapies","volume":"5","author":"Suzuki","year":"1995","journal-title":"Brain Pathol"},{"key":"2022011210343332600_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mt.6300026","article-title":"Central nervous system-directed AAV2\/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy","volume":"15","author":"Lin","year":"2007","journal-title":"Mol Ther"},{"key":"2022011210343332600_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbd.2005.07.016","article-title":"The therapeutic potential of neural stem\/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage\/microglia activation","volume":"21","author":"Pellegatta","year":"2006","journal-title":"Neurobiol Dis"},{"key":"2022011210343332600_bib14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.6382609","article-title":"Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse","volume":"225","author":"Yeager","year":"1984","journal-title":"Science"},{"key":"2022011210343332600_bib15","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI113521","article-title":"Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse","volume":"81","author":"Hoogerbrugge","year":"1988","journal-title":"J Clin Invest"},{"key":"2022011210343332600_bib16","first-page":"302","article-title":"The twitcher mouse. Central nervous system pathology after bone marrow transplantation","volume":"58","author":"Suzuki","year":"1988","journal-title":"Lab Invest"},{"key":"2022011210343332600_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","article-title":"Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J"},{"key":"2022011210343332600_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.gt.3301495","article-title":"Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements","volume":"8","author":"Shen","year":"2001","journal-title":"Gene Ther"},{"key":"2022011210343332600_bib19","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1097\/00001756-199812010-00011","article-title":"Retroviral-mediated transfer of the galactocerebrosidase gene in neural progenitor cells","volume":"9","author":"Torchiana","year":"1998","journal-title":"NeuroReport"},{"key":"2022011210343332600_bib20","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.2006.03986.x","article-title":"Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: Evidence from a mouse model of Krabbe leukodystrophy","volume":"97","author":"Taylor","year":"2006","journal-title":"J Neurochem"},{"key":"2022011210343332600_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ymgme.2004.12.007","article-title":"GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo","volume":"84","author":"Meng","year":"2005","journal-title":"Mol Genet Metab"},{"key":"2022011210343332600_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymthe.2005.04.019","article-title":"AAV2\/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2","volume":"12","author":"Lin","year":"2005","journal-title":"Mol Ther"},{"key":"2022011210343332600_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14653240600879152","article-title":"Neural transplantation of human MSC and NT2 cells in the twitcher mouse model","volume":"8","author":"Croitoru-Lamoury","year":"2006","journal-title":"Cytotherapy"},{"key":"2022011210343332600_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(03)00633-5","article-title":"Substrate reduction intervention by L-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST\/Ei background","volume":"347","author":"Biswas","year":"2003","journal-title":"Neurosci Lett"},{"key":"2022011210343332600_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-200201000-00009","article-title":"Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy","volume":"51","author":"Biswas","year":"2002","journal-title":"Pediatr Res"},{"key":"2022011210343332600_bib26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jnr.22006","article-title":"Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease","volume":"87","author":"Galbiati","year":"2009","journal-title":"J Neurosci Res"},{"key":"2022011210343332600_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br J Haematol"},{"key":"2022011210343332600_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","article-title":"Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation","volume":"11","author":"Le Blanc","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022011210343332600_bib29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.coi.2006.07.004","article-title":"Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation","volume":"18","author":"Le Blanc","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2022011210343332600_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/157488806778226821","article-title":"Adult mesenchymal stem cells: A pluripotent population with multiple applications","volume":"1","author":"Porada","year":"2006","journal-title":"Curr Stem Cell Res Ther"},{"key":"2022011210343332600_bib31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"2022011210343332600_bib32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1634\/stemcells.2005-0235","article-title":"The immunogenicity of human adipose-derived cells: Temporal changes in vitro","volume":"24","author":"McIntosh","year":"2006","journal-title":"Stem Cells"},{"key":"2022011210343332600_bib33","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Yanez","year":"2006","journal-title":"Stem Cells"},{"key":"2022011210343332600_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1227\/01.NEU.0000141042.14476.3C","article-title":"Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain","volume":"55","author":"Mahmood","year":"2004","journal-title":"Neurosurgery"},{"key":"2022011210343332600_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1711.2006.01458.x","article-title":"Mesenchymal stem cells in immunoregulation","volume":"84","author":"Chen","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"2022011210343332600_bib36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonzalez","year":"2009","journal-title":"Gastroenterology"},{"key":"2022011210343332600_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/art.24405","article-title":"Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells","volume":"60","author":"Gonzalez","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022011210343332600_bib38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut"},{"key":"2022011210343332600_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mt.2009.62","article-title":"Repair of tissues by adult stem\/progenitor cells (MSCs): Controversies, myths, and changing paradigms","volume":"17","author":"Prockop","year":"2009","journal-title":"Mol Ther"},{"key":"2022011210343332600_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnen\/60.11.1062","article-title":"Expression of immune-related molecules is downregulated in twitcher mice following bone marrow transplantation","volume":"60","author":"Wu","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022011210343332600_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.01-0798com","article-title":"Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C\/EBP: Implications for Krabbe disease","volume":"16","author":"Giri","year":"2002","journal-title":"FASEB J"},{"key":"2022011210343332600_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-2-10","article-title":"Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model","volume":"2","author":"Kagitani-Shimono","year":"2005","journal-title":"J Neuroinflammation"},{"key":"2022011210343332600_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jcp.21070","article-title":"Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients","volume":"212","author":"Formichi","year":"2007","journal-title":"J Cell Physiol"},{"key":"2022011210343332600_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2353\/ajpath.2008.070404","article-title":"Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy","volume":"172","author":"Borda","year":"2008","journal-title":"Am J Pathol"},{"key":"2022011210343332600_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2121-10-3","article-title":"Comparative characterization of mesenchymal stem cells from eGFP transgenic and non-transgenic mice","volume":"10","author":"Ripoll","year":"2009","journal-title":"BMC Cell Biol"},{"key":"2022011210343332600_bib46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0092-8674(94)90529-0","article-title":"Absence of MHC class II molecules reduces CNS demyelination, microglial\/macrophage infiltration, and twitching in murine globoid cell leukodystrophy","volume":"78","author":"Matsushima","year":"1994","journal-title":"Cell"},{"key":"2022011210343332600_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(86)90111-6","article-title":"Optimal assay conditions for enzymatic characterization of homozygous and heterozygous twitcher mouse","volume":"877","author":"Raghavan","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"2022011210343332600_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","article-title":"Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy","volume":"106","author":"Hawkes","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011210343332600_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2009.09.017","article-title":"Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy","volume":"1300","author":"Luzi","year":"2009","journal-title":"Brain Res"},{"key":"2022011210343332600_bib50","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1172\/JCI119782","article-title":"Inducible nitric oxide synthase: What difference does it make?","volume":"100","author":"Nathan","year":"1997","journal-title":"J Clin Invest"},{"key":"2022011210343332600_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-201X.2001.00891.x","article-title":"Role of nitric oxide in inflammation","volume":"173","author":"Laroux","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"2022011210343332600_bib52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20051529","article-title":"Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase","volume":"202","author":"Nathan","year":"2005","journal-title":"J Exp Med"},{"key":"2022011210343332600_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022011210343332600_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2022011210343332600_bib55","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"2022011210343332600_bib56","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.exphem.2005.05.002","article-title":"Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells","volume":"33","author":"Groh","year":"2005","journal-title":"Exp Hematol"},{"key":"2022011210343332600_bib57","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","article-title":"Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism","volume":"25","author":"Djouad","year":"2007","journal-title":"Stem Cells"},{"key":"2022011210343332600_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"2022011210343332600_bib59","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"2022011210343332600_bib60","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.555","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.555","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.555","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/29\/1\/67\/41965669\/stmcls_29_1_67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/29\/1\/67\/41965669\/stmcls_29_1_67.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T03:09:53Z","timestamp":1642561793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/29\/1\/67-77\/6403511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,28]]},"published-print":{"date-parts":[[2011,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.555","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,1,1]]},"published":{"date-parts":[[2011,1,1]]}}}